These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7914563)

  • 1. Relation between human papillomavirus type 16 and potential for progression of minor-grade cervical disease.
    Downey GP; Bavin PJ; Deery AR; Crow J; Griffiths PD; Emery VC; Walker PG
    Lancet; 1994 Aug; 344(8920):432-5. PubMed ID: 7914563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
    Kjær SK; Frederiksen K; Munk C; Iftner T
    J Natl Cancer Inst; 2010 Oct; 102(19):1478-88. PubMed ID: 20841605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the effectiveness of HPV16/18 infection referred for colposcopy in cervical cancer screening in Northwest of China.
    Zhang Q; Zhao M; Cao D; Wei X; Wang L; Li Y; Yang T; Zhao J; Pei M; Jia H; Cao S; Quan S; Yang X
    J Med Virol; 2018 Jan; 90(1):165-171. PubMed ID: 28710863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Much higher risk of premalignant and malignant cervical diseases in younger women positive for HPV16 than in older women positive for HPV16.
    Tanaka H; Karube A; Tanaka T; Nakagomi O
    Microbiol Immunol; 2001; 45(4):323-6. PubMed ID: 11386424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia.
    de Gruijl TD; Bontkes HJ; Walboomers JM; Schiller JT; Stukart MJ; Groot BS; Chabaud MM; Remmink AJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ
    J Natl Cancer Inst; 1997 May; 89(9):630-8. PubMed ID: 9150187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy.
    Schneider A; Hoyer H; Lotz B; Leistritza S; Kühne-Heid R; Nindl I; Müller B; Haerting J; Dürst M
    Int J Cancer; 2000 Nov; 89(6):529-34. PubMed ID: 11102899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of cervical intraepithelial neoplasia in women with atypical squamous or glandular cells of undetermined significance cytology: a prospective study.
    Wensveen C; Kagie M; Veldhuizen R; De Groot C; Denny L; Zwinderman K; Trimbos B
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):883-9. PubMed ID: 12911453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.
    Muñoz N; Kjaer SK; Sigurdsson K; Iversen OE; Hernandez-Avila M; Wheeler CM; Perez G; Brown DR; Koutsky LA; Tay EH; Garcia PJ; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Steben M; Bosch FX; Dillner J; Huh WK; Joura EA; Kurman RJ; Majewski S; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan JT; Lupinacci LC; Giacoletti KE; Sings HL; James MK; Hesley TM; Barr E; Haupt RM
    J Natl Cancer Inst; 2010 Mar; 102(5):325-39. PubMed ID: 20139221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of cervical intraepithelial neoplasia: the role of human papillomavirus.
    Cox JT
    Baillieres Clin Obstet Gynaecol; 1995 Mar; 9(1):1-37. PubMed ID: 7600720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papilloma virus testing in patient follow-up post cone biopsy due to high-grade cervical intraepithelial neoplasia.
    Almog B; Gamzu R; Kuperminc MJ; Levin I; Fainaru O; Niv J; Bar-Am A
    Gynecol Oncol; 2003 Mar; 88(3):345-50. PubMed ID: 12648585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance.
    Denise Zielinski G; Snijders PJ; Rozendaal L; Voorhorst FJ; Runsink AP; de Schipper FA; Meijer CJ
    J Pathol; 2001 Oct; 195(3):300-6. PubMed ID: 11673826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up by combined cytology and human papillomavirus testing for patients post-cone biopsy: results of a long-term follow-up.
    Bar-Am A; Gamzu R; Levin I; Fainaru O; Niv J; Almog B
    Gynecol Oncol; 2003 Oct; 91(1):149-53. PubMed ID: 14529675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease.
    Gravitt PE; Kovacic MB; Herrero R; Schiffman M; Bratti C; Hildesheim A; Morales J; Alfaro M; Sherman ME; Wacholder S; Rodriguez AC; Burk RD
    Int J Cancer; 2007 Dec; 121(12):2787-93. PubMed ID: 17722112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.
    Khan MJ; Castle PE; Lorincz AT; Wacholder S; Sherman M; Scott DR; Rush BB; Glass AG; Schiffman M
    J Natl Cancer Inst; 2005 Jul; 97(14):1072-9. PubMed ID: 16030305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study.
    Dalstein V; Riethmuller D; Prétet JL; Le Bail Carval K; Sautière JL; Carbillet JP; Kantelip B; Schaal JP; Mougin C
    Int J Cancer; 2003 Sep; 106(3):396-403. PubMed ID: 12845680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple human papillomavirus infection with or without type 16 and risk of cervical intraepithelial neoplasia among women with cervical cytological abnormalities.
    Spinillo A; Gardella B; Roccio M; Alberizzi P; Cesari S; Patrizia M; Silini E
    Cancer Causes Control; 2014 Dec; 25(12):1669-76. PubMed ID: 25296710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk stratification of type-specific human papillomavirus for cervical precancers: evidence from a cross-sectional study in Shenzhen].
    Liu ZH; Lin W; Wang YY; Wu B; Yuan SX; Yao JL; Zhao XS; Chen B; Qiao YL; Zhao FH; Chen W; Hu SY
    Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):757-763. PubMed ID: 30392340
    [No Abstract]   [Full Text] [Related]  

  • 19. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus vaccination history and diagnosis of cervical intraepithelial neoplasia grade ≥2 severe lesions among a cohort of women who underwent colposcopy in Kaiser Permanente Southern California.
    Lonky NM; Xu L; Da Silva DM; Felix JC; Chao C
    Am J Obstet Gynecol; 2021 Dec; 225(6):656.e1-656.e11. PubMed ID: 34273278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.